NASDAQ:GNPX

Genprex, Inc.

Stock

USD

Last Close

1.94

26/07 20:00

Market Cap

3.88M

Beta: −0.34

Volume Today

15.16K

Avg: 589.16K

PE Ratio

−12.64

PFCF: −0.42

Overview Financials Filings people Ownership API Chart Data

locale
United States
market
STOCKS
industry
Biotechnology
website
www.genprex.com
ipo date
Mar 29, 2018

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquarte...Show More

NASDAQ:GNPX

Genprex, Inc.

Last Close

1.94

26/07 20:00

Market Cap

3.88M

Beta: −0.34

Volume Today

15.16K

Avg: 589.16K

PE Ratio

−12.64

PFCF: −0.42

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics